CDC vaccine panel holds first meeting since RFK Jr. put immunization critics in place

CDC vaccine panel holds first meeting since RFK Jr. put immunization critics in place


A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia.

Tami Chappell | Reuters

A crucial government panel of vaccine advisors will hold its first meeting Wednesday since Health and Human Services Secretary Robert F. Kennedy Jr. appointed several vaccine critics to the group. 

Earlier this month, Kennedy in a stunning step removed and replaced all members of the Advisory Committee on Immunization Practices, or ACIP, which advises the Centers for Disease Control and Prevention. The group reviews vaccine data and makes recommendations that determine who is eligible for shots and whether insurers should cover them, among other efforts.

It is unclear how Kennedy’s new members, given some of their skepticism of immunizations, will affect vaccine policy and availability in the U.S. 

During a full-day meeting Wednesday in Atlanta, the panel will evaluate data on Covid-19 vaccines and RSV shots, with a vote on recommendations for the latter. The group will convene again on Thursday to review data on shots for the flu and other diseases. 

The CDC director has to sign off on those recommendations for them to become official policy.

ACIP members are independent medical and public experts who make recommendations based on rigorous scientific review and evidence. But Kennedy’s eight new members include some well-known vaccine critics, such as Dr. Robert Malone.

Malone bills himself as having played a key role in the creation of mRNA vaccines, but has gained a large following for making baseless and disproven claims about Covid-19 shots. 

Another new member, Retsef Levi, has pushed to stop giving mRNA vaccines, falsely claiming in a post on X that they cause “serious harm including death, especially among young people.” 

The meeting on Wednesday will begin at 10 a.m. ET. 



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More